Skip to main content

Table 1 Clinical summary of application of PGS on frozen/warmed blastocysts

From: Assessment of clinical application of preimplantation genetic screening on cryopreserved human blastocysts

Age (range)

≤35 (28–34)

≤36 (36–44)

Egg donor

Total

No. of cases

17

16

2

35

No. of embryos warmed

121

98

15

234

No. (%) of embryos survived

119 (98.3)

60 (91.8)

15 (100)

224 (95.7)

No. of embryos biopsied

119

90

15

224

No. (%) of samples without test results

1 (0.8)

1 (1.1)

1 (6.7)

3 (1.3)

No. (%) of embryos with test results

118 (99.2)

89 (98.8)

14 (93.3)

221 (98.7)

No. (%) of normal embryos

72 (61.0)

51 (57.3)

8 (57.1)

131 (59.3)

No. (%) of abnormal embryos

46 (38.9)

38 (42.7)

6 (42.9)

90 (40.7)

No. of transfer

17

15a

2

34

No. (%) of clinical pregnancy

9 (52.9)

7 (46.7)

2 (100)

18 (52.9)

No. of delivery and ongoing pregnancy

6 (35.3)

6 (40.0)

2 (100)

14 (41.2)

No. of embryos transferred

32

25

4

61

No. (%) of embryos implanted

13 (40.6)

10 (40.0)

3 (75.0)

26 (42.6)

  1. aOne patient did not have transfer due to all abnormal embryos